Takeda wins US approval for new CMV treatment
Livtencity is part of the first wave of new products Takeda hopes will reposition the company as a top player in the pharmaceutical industry for years to come. Earlie...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement